Top 50 Biotech VC Funds & Investors in Spain (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
26 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $155k–$19M |
|
Inveready
VC Fund
|
15 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $400k–$14M |
|
Criteria Venture Tech
VC Fund
|
15 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
SODENA
VC Fund
|
14 | Spain, United Kingdom | Debt Financing, Seed | Health Care, Biotechnology, Manufacturing | $37k–$937k |
|
Clave Capital
VC Fund
|
13 | Spain, Chile, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $527k–$16M |
|
ENISA
VC Fund
|
12 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$2.2M |
|
Invivo Capital Partners
VC Fund
|
11 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$71M |
|
Ysios Capital
VC Fund
|
10 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.2M–$135M |
|
Asabys Partners
VC Fund
|
10 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$135M |
|
Capital Cell
VC Fund
|
9 | Spain, France, United States | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | $137k–$1.9M |
|
Alta Life Sciences
VC Fund
|
9 | Spain, United States | Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical Device | $3M–$33M |
|
ICF Capital
VC Fund
|
9 | Spain, United States, Mexico | Debt Financing, Seed | Software, Health Care, Biotechnology | $146k–$6.9M |
|
Bullnet Capital
VC Fund
|
8 | Spain, United States, Mexico | Seed, Series A | Software, Information Technology, Manufacturing | $590k–$11M |
|
BeAble Capital
VC Fund
|
8 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
Xesgalicia
VC Fund
|
7 | Spain, Portugal | Seed, Pre-Seed | Software, Biotechnology, Pharmaceutical | $304k–$5.9M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
7 | Spain, Switzerland | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $266k–$16M |
|
CRB Inverbío
VC Fund
|
7 | Spain, Italy, Mexico | Series A, Seed | Health Care, Medical, Biotechnology | $2.2M–$8.9M |
|
SOSV
VC Fund
|
6 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
AdBio partners
VC Fund
|
6 | France, Spain, Belgium | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Moira Capital Partners
VC Fund
|
5 | Spain | Series A, Private Equity | Biotechnology, Information Technology, Apps | $11M–$18M |
|
BStartup
VC Fund
|
5 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.2M |
|
Gestion De Capital Riesgo Del Pais Vasco
VC Fund
|
4 | Spain | Seed, Series A | Biotechnology, Health Care, Medical | $213k–$14M |
|
CDTI
VC Fund
|
4 | Spain, United States, Mexico | Seed, Debt Financing | Software, Information Technology, Health Care | $274k–$2.6M |
|
Clave Mayor
VC Fund
|
4 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
Angels Capital
VC Fund
|
4 | Spain, United States, Ireland | Seed, Angel | Software, E-Commerce, Health Care | $104k–$2.7M |
|
Amadeus Capital Partners
VC Fund
|
4 | United Kingdom, United States, Spain | Series B, Seed, Series A | Software, Artificial Intelligence, Information Technology | $900k–$43M |
|
Columbus Venture Partners
VC Fund
|
3 | Spain, United States, United Kingdom | Seed, Series A | Biotechnology, Health Care, Medical | $1.7M–$53M |
|
Pirate Impact
VC Fund
|
3 | Spain, Denmark, Germany | Seed, Series C | Renewable Energy, Fuel, EdTech | |
|
Union Square Ventures
VC Fund
|
3 | United States, United Kingdom, Canada | Series A, Series B, Seed | Software, Financial Services, FinTech | $2M–$40M |
|
AVANTECA Partners
VC Fund
|
3 | Spain, Switzerland | Seed, Series A | Biotechnology, Health Care, Security | $1.1M–$2.7M |
|
Grow Venture Partners
VC Fund
|
3 | Spain | Seed, Pre-Seed | Health Care, Artificial Intelligence, Software | $137k–$11M |
|
Seed Capital Bizkaia
VC Fund
|
3 | Spain, Mexico, Belgium | Seed, Series A | Software, Biotechnology, Health Care | $119k–$14M |
|
AENU
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A, Series B | Renewable Energy, Software, CleanTech | $2.4M–$88M |
|
Startupxplore
VC Fund
|
3 | Spain | Seed, Pre-Seed, Equity Crowdfunding | Artificial Intelligence, Health Care, Software | $111k–$2.5M |
|
APEX Ventures
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $511k–$28M |
|
Talis Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Information Technology, E-Commerce | $1M–$30M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$26M |
|
Blue Horizon Corporation
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $450k–$28M |
|
Buenavista Equity Partners
VC Fund
|
2 | Spain, Ecuador, Romania | Private Equity, Seed, Series A | Biotechnology, Health Care, Restaurants | $2.9M–$50M |
|
Nara Capital
VC Fund
|
2 | Spain | Seed | Biotechnology, Life Science, Medical | |
|
Healthequity
VC Fund
|
2 | Spain, Switzerland | Series B, Series A, Series D | Health Care, Biotechnology, Medical | |
|
Kereon Partners
VC Fund
|
2 | Spain | Seed | Health Care, Cooking, Medical | |
|
BAGi
VC Fund
|
2 | Spain, Norway, Switzerland | Seed, Angel | Internet, Health Care, Information Technology | |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Spain | Seed, Series A | Medical Device, Financial Services, Medical | |
|
Elaia
VC Fund
|
2 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | |
|
Faber
VC Fund
|
2 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | |
|
Santander
VC Fund
|
2 | United Kingdom, Spain, United States | Debt Financing, Post-IPO Debt, Seed | Energy, Renewable Energy, Financial Services | $100k–$1.3B |
|
Archipelago Next
VC Fund
|
2 | Spain, United States | Seed, Pre-Seed | Software, SaaS, Information Technology | $276k–$3.1M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
EASO Ventures
VC Fund
|
2 | Spain, Switzerland | Seed, Series A | Software, Health Care, Manufacturing | $266k–$3.2M |
| Access all 349 VC funds in Spain Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 186
- Round size: Seed $562k–$5.9M; Grant $155k–$19M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- TetraxAI — TetraxAI helps renewable energy developers and investors automate due diligence and risk assessment - 100x faster, 10x cheaper, with full legal traceability.
- Golden Owl —
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 157
- Round size: Seed $400k–$5.5M; Series A $1.6M–$14M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- RITMO — Ritmo helps digital entrepreneurs grow faster, through non-dilutive funding and growth tools. Targeted specifically at E-commerce and SaaS companies, as well as any digital entrepreneur with recurring or predictable revenue.
- Qbeast Analytics — Qbeast Analytics SL is a spin-off of the Barcelona Supercomputing Center (BSC). Qbeast is a Big Data cloud platform with a patented data storage technology that reorganizes and manages data through multidimensional indexing and sampling techniques so that it can be analyzed up to 100 times faster. Qbeast provides data teams with the option toadjust the precision of data analytics to produce high-quality insights while only accessing a fraction of the available data. This speeds up their work massively and at the same time produces savings on computational resources and energy.
- StereoDive —
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 151
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Debt Financing, Seed
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 87
- Round size: Seed $110k–$937k; Debt Financing $37k–$743k
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- DARWIN Biomed — Biomedical Engineering
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
- El Caserío de Tafalla — El Caserío de Tafalla is a food production company that processes and supplies a variety of candies.
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 40
- Round size: Seed $527k–$5.5M; Series A $4.9M–$16M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Innitius — AI-powered obstetric diagnostics for improved preterm birth risk assessment.
- Sincrolab — Descubre Sincrolab, el tratamiento digital que utiliza inteligencia artificial para mejorar los procesos cognitivos. Con eficacia validada en TDAH
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 190
- Round size: Seed $76k–$2.2M; Pre-Seed $186k–$1.2M; Debt Financing $66k–$494k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Swipoo — Transferencia de vehículos y cambio de nombre automatizado.
- TucanPay — TucanPay is a money transfer platform that sends money between continents.
- DARWIN Biomed — Biomedical Engineering
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 24
- Round size: Seed $1.6M–$13M; Series A $2.2M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 79
- Round size: Series A $2.2M–$63M; Series B $17M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Cytoki Pharma — Cytoki Pharma is a biotechnology company developing a portfolio of IL-22-based drugs as a new treatment paradigm for serious diseases involving epithelial injury.
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 36
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $19M–$135M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
- Nuage Therapeutics — Nuage Therapeutics is a pharmaceutical company which utilizes chemical biology and biomolecular condensation to develop selective drugs that target proteins with disordered regions for challenging indications to improve patient’s life. The focus of the medication is to enhance selective inhibitors of intrinsically disordered proteins involved inchallenging indications in order to meet unmet medical needs.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, France, United States
Investor stats
- Total investments: 51
- Round size: Seed $384k–$1.9M; Equity Crowdfunding $137k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- EVerZom — EVerZom is an exosome biotech company developing exosome therapeutics in digestive tissue healing, fistula and organ regeneration.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- EVis Bioscience — EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Venture - Series Unknown
- Geography: Spain, United States
Investor stats
- Total investments: 17
- Round size: Series A $3M–$33M; Venture - Series Unknown $5.8M–$12M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 105
- Round size: Seed $1.1M–$6.9M; Debt Financing $146k–$1.7M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Bookline — Bookline is a company which offers AI-based conversational bots to manage appointments and bookings over the phone.
- Bigle Legal — Empower your team with next-gen document automation
- Top Doctors — Top Doctors is an online platform for identifying, interacting, and booking e-consultations with medical specialists in private healthcare. The company represents over 60,000 of the world’s top physicians and uses the latest innovation and technology to bring them closer to the patients. Top Doctors represents doctors in the US, Europe, and LatinAmerica. The company has become a reference for providing trustworthy and up-to-date information on choosing leading national and international medical professionals, covering the full range of specialties and all the latest medical treatments. The company accounts for over 1 million users on its site per month, and it has satisfied over 10 million patients’ needs when selecting the best doctors from all around the world.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 60
- Round size: Seed $1M–$3.3M; Series A $590k–$11M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — FlexiiC is a deep-tech firm developing printed, flexible integrated circuits for sustainable IoT and smart packaging solutions.
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues and cells. We are focusing the application of our technology in fields like Mechanobiology where the study of diseases directly related with cell migration or development are demanding new techniques. We offer cutting-edge non-invasive to...
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 67
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$274k
- Lead/follow: 82% lead, 18% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Calpech — Calpech focuses on technology and innovation based on this description, here are a few potential characteristics and strengths.
- ALA Diagnostics — ALA Diagnostics develops and markets in vitro Diagnostic Kits for pathologies with high prevalence and/or unresolved medical needs, based on existing synergies with some of the Public Organizations with the greatest capacity to generate innovative projects.
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 33
- Round size: Seed $304k–$5.9M; Pre-Seed $439k–$2.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs.
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 47
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Zoundream — The Future of Infant Care
- Nanoligent — Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Italy, Mexico
Investor stats
- Total investments: 14
- Round size: Seed $3.3M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $70M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 31
- Round size: Seed $2.2M–$18M; Series A $19M–$37M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $116M in 2021
Portfolio highlights
- DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Moira Capital Partners is private equity firm
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Apps
- Stage:Series A, Private Equity
- Geography: Spain
Investor stats
- Total investments: 13
- Round size: Private Equity $11M–$18M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- NeuronUP — NeuronUP is a platform that provides professionals the ability to access real, when and where they want their exercise routines and their patients time manager and interact directly with their team of professionals in a specialized environment. All this generates a continuous updating of information and content platform, arising from theinter-professional dialogue.
- Voovio — Voovio's Simulation Software enables the process industry to avoid errors during SOP execution, reducing downtime & increasing safety in operations & maintenance.
- Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 81
- Round size: Seed $110k–$2.2M; Pre-Seed $110k–$2.2M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- TietAI — TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 22
- Round size: Seed $213k–$878k; Series A $329k–$14M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Irisbond — Irisbond creates a new way for humans to communicate through precision eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Developed for use in mobile devices, automotive, smart homes, robotics, scientific,healthcare and manufacturing, eye tracking technology lets you learn, play, work and communicate with your eyes. A pioneer in the assistive technology market, Irisbond’s eye tracking solutions are based on years of R&D in cooperation with Vicomtech, a leader in the field of artificial vision. For more information about the power of the eyes, go to www.irisbond.com/en
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Inmedical Therapeutics — Innovative medical devices designed to meet real clinical needs, combining science, know-how and therapeutic research.
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Debt Financing
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 33
- Round size: Seed $285k–$2.6M; Debt Financing $274k–$472k
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel
- Geography: Spain, United States, Ireland
Investor stats
- Total investments: 119
- Round size: Seed $265k–$2.7M; Angel $104k–$1.6M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- NovaHiring — NovaHiring is a startup that automates and optimizes recruitment processes through the use of intelligent agents and AI-powered analytics, helping organizations source, screen, and hire talent more efficiently while improving decision quality and reducing time to hire.
- VICO Ahorro — VICO Ahorro uses a digital system that evaluates, compares, and automatically manages the best market offers to help consumers save money on regular costs like energy, insurance, and telecommunications.
- ODOS — Carbon Harvesters is an ag-tech start-up that increases the resilience of rural communities by facilitating cost-effective decarbonisation of the dairy sector.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series B, Seed, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 234
- Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$43M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Pimloc — Pimloc's deep learning platform enables private businesses and public organisations to protect sensitive or personal data in video, to maintain safe online environments and to manage video security.
- XYZ Reality — XYZ Reality - The world's first Engineering-Grade augmented reality system for construction.
- Altana — Altana powers trusted trade for governments and businesses worldwide. Map supply chains, manage tariffs, ensure compliance, and build resilience with AI.
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate theircommercialization.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 25
- Round size: Seed $1.7M–$13M; Series A $27M–$53M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $127M in 2021
Portfolio highlights
- SANIFIT — CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
- Artax Biopharma — Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Pirate Impact is a Family office with focus on stage-agnostic direct investments in climate-tech & social impact companies in the EU & US.
Show more...Investment focus
- Industry: Renewable Energy, Fuel, EdTech
- Stage:Seed, Series C
- Geography: Spain, Denmark, Germany
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Labster — Labster empowers educators to reimagine their science courses with immersive online simulations. Request a demo to discover how Labster engages students, trains lab skills, and accelerates learning.
- Minimum — Take control of your organization's carbon accounting and management with granular, robust and auditable emissions data.
Union Square Ventures is a venture capital firm based in New York City.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 414
- Round size: Seed $2M–$15M; Series A $3.2M–$24M; Series B $5.5M–$40M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2022
Portfolio highlights
- Veniam — Transfer 10x more data for your video telematics, fleet operations, industrial IoT or connected vehicles.
- Tandems — Tandems enhances the way financial advice is delivered by equipping advisors, bankers, and agents with data-driven insights and personalized recommendations. Tandems focuses on improving institutional operations through automation and intelligent decision-support tools that streamline workflows and client engagement. The company’s technology isdesigned to augment human expertise, allowing financial professionals to allocate more time to strategic guidance and relationship building.
- Mundi — Mundi provides financial, trade development, strategy, freight and reinventing international trade services.
A privately held asset management company that invests in early-stage life science companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Security
- Stage:Seed, Series A
- Geography: Spain, Switzerland
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$2.7M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Bearmind — Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.
- Nanoligent — Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
- Onena Medicines — Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 19
- Round size: Seed $549k–$11M; Pre-Seed $137k–$2.5M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine
Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de Innovación y Promoción Económica de la Diputación Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Spain, Mexico, Belgium
Investor stats
- Total investments: 34
- Round size: Seed $119k–$2.9M; Series A $2.7M–$14M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- NNEAT — NNEAT operationalizes Continuous Threat Exposure Management (CTEM) and powers MITRE ATT&CK®-aligned Threat-Informed Defense (TID).
- Emica Solar — Emica Solar is a company which develops the floating solar energy.
- Revenant Industrial & Ports Machinery — Revenant returning to the revolution in internal logistics, container manipulators, and the remanufacturing of large tonelaje carretillas.
AENU is an evergreen impact fund that focuses on stage-agnostic long-term investments in climate-tech and social impact companies.
Show more...Investment focus
- Industry: Renewable Energy, Software, CleanTech
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 60
- Round size: Seed $2.4M–$11M; Series A $8M–$53M; Series B $11M–$88M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- trawa — The partner for renewable and affordable electricity for businesses. Get electricity directly from solar and windparks with corporate PPAs.
- Equitable Earth — Built upon next-generation digital MRV, the Equitable Earth Standard is designed to verify impact on climate, biodiversity, and livelihoods.
- Minimum — Take control of your organization's carbon accounting and management with granular, robust and auditable emissions data.
Startupxplore is a premium startup investment platform that allows unexperienced and time-savvy investors to diversify their portfolio by co-investing with a group of top-level investors with a proven track record on startup investment.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Seed, Pre-Seed, Equity Crowdfunding
- Geography: Spain
Investor stats
- Total investments: 25
- Round size: Seed $276k–$870k; Pre-Seed $111k–$2.5M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Heuristik — Heuristik is a software solution that helps healthcare entities identify and manage patients by combining fingerprint recognition and artificial intelligence. They help with process planning and the administrative management of patients through the use of statistical analysis and proprietary management algorithms.
- Biel Glasses — Biel Glasses is a company from Barcelona developing smart glasses to improve the quality of life of people with low vision.
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 57
- Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $5.2M–$28M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
We back founders who see the future differently.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 81
- Round size: Seed $1M–$13M; Series A $3M–$24M; Series B $10M–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- Beyond — Write your will online, apply for probate or arrange a meaningful funeral.
- IOTICS — We are changing how the world uses and shares data. Enabling secure, trusted data interactions for everything and everyone, in real-time, at scale. The challenge facing industries is one of access to, and security of, data. The problem isn't that the data doesn't exist it's that we can't securely access it where we need itwhen we need. System integrations, centralisation and point to point solutions are costly, duplicate date, and increase risk of failure.The solution is a secure ecosystem of data interactions, filtering what matters at source and channelling it to where it's needed. Data is not duplicated. Re-architecting is avoided as new sources/consumers added Secure data interactions minimise time to market, reduce costs and mitigate risk. Delivering value within a quarter.Our solution IOTICSpace, is cloud-hosted software, in which data becomes Findable Accessible, Interoperable and Reusable. Secure-by-design IOTICS creates a data mesh of sources and consumers of data using Digital Twins, virtual versions of anything (assets, data, algorithms). Delivering scalable building blocks for your data strategy, without locking you in to architectural choices.
- Clausematch — Our award-winning policy management, regulatory change management and compliance platform automates time-sucking tasks, organises your data and makes collaboration and knowledge-sharing a breeze. Learn more here
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 41
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$26M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
- Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
- Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 94
- Round size: Seed $2M–$12M; Pre-Seed $450k–$6.3M; Series A $2M–$28M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $187M in 2021
Portfolio highlights
- WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
- foodforecast — AI supported solution to reduce food waste.
GED is an independent Private Equity group operating in the Iberian Peninsula and South-Eastern Europe. The company was incorporated in 1996 and GED’s professional Partners hold a majority stake in the Management Companies of the Group.GED is positioned in the middle market, managing funds in excess of €300M through 4 different Private Equityvehicles and operates in two different private equity sectors; private equity and private equity-real estate.GED Private Equity is looking at buyouts and expansion deals maximizing the portfolio value through a clear buy and build strategy in the core countries: Romania, Bulgaria, Spain and Portugal, backing medium size companies that can become regional market leaders.GED Opportunity targets opportunistic and value added real estate investments in South Eastern Europe.GED has a strong track record in Eastern Europe and the Iberian Peninsula, achieved it during its 19 years activity in the region through offices in Madrid, Seville, Bucharest, Sofia and Oporto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Restaurants
- Stage:Private Equity, Seed, Series A
- Geography: Spain, Ecuador, Romania
Investor stats
- Total investments: 15
- Round size: Seed $2.9M–$4.4M; Series A $8M–$50M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $117M in 2019
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- Eranovum — Eranovum manages the development and construction of renewable energy projects in Spain using new era energy infrastructure.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
- Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Healthequity is a venture capital company specializing in early-stage projects in the health sector: medical devices, biotechnology and healthcare services. It is a fund promoted by the Official College of Physicians of Barcelona and the financial group Riva y Garcia that is looking for projects to make their first investments. Healthequity has ateam of professionals with complementary experience, with the scientific-technical and financial know-how necessary to analyze and make investments contributing value to the investee company. In addition, it has a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series D
- Geography: Spain, Switzerland
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- SANIFIT — CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Versantis — Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, iscurrently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.
> smart projects
Show more...Investment focus
- Industry: Health Care, Cooking, Medical
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
- Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
- Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more...Investment focus
- Industry: Internet, Health Care, Information Technology
- Stage:Seed, Angel
- Geography: Spain, Norway, Switzerland
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Medical Device, Financial Services, Medical
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 51
- Lead/follow: no public data
Portfolio highlights
- 1849 Bio — 1849 Bio creates microbes for affordable metal extraction from low-grade copper and gold ores.
- Scout AI — Scout AI is building the robotic foundation model for defense.
- Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 196
- Lead/follow: no public data
Portfolio highlights
- Pili — PiLi biofabricates a sustainable alternative to create renewable inks to replace their toxic, non-biological, and non-recyclable versions.Pili was born from the reunion of a biologist, a designer, and a financial analyst at the biohacker space La Paillasse in Paris and with the creation of the first pen fed by bacteria. Its team is nowdedicated to providing the colors from micro-organisms to offer a sustainable alternative to fossil resources.
- Djust — DJUST is the dedicated solution that helps companies launch their B2B eCommerce and eProcurement platforms faster
- SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 75
- Lead/follow: no public data
Portfolio highlights
- YPLASMA — YPlasma, an INTA spin-off, develops plasma actuators for ionic flow control, enabling advancements in Energy and Electronics.
- KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
- Zymvol Biomodeling — Need a new or better biocatalyst? At ZYMVOL we combine bioinformatics and molecular modeling to accelerate Enzyme Discovery and Design
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Financial Services
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: United Kingdom, Spain, United States
Investor stats
- Total investments: 99
- Round size: Seed $100k–$3.3M; Post-IPO Debt $13M–$549M; Debt Financing $14M–$1.3B
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $658M in 2019
Portfolio highlights
- suena — We are revolutionizing the way energy storage and renewables are integrated into power trading. By using cutting-edge forecasting, optimization and algorithmic trading techniques, we're able to reduce risks, maximize as well as stabilize profits on electricity and balancing markets.
- NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
- InstaVolt — InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle.They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastestcharging available.They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions.Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution.According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country.They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.
Archipelago Next support and promote the entrepreneurial ecosystem.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Spain, United States
Investor stats
- Total investments: 33
- Round size: Seed $276k–$3.1M; Pre-Seed $991k–$1.2M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Secrets Vault —
- Dolfin — Dolfin is a software company that provides automated sales compensation solutions for businesses.
- CareerOS —
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 132
- Round size: Seed $2.3M–$13M; Series A $3.8M–$95M; Series B $8.8M–$80M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Spain, Switzerland
Investor stats
- Total investments: 74
- Round size: Seed $266k–$3.2M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Normo — Normo provides end-to-end encrypted hardware and software capable of receiving shipments from any courier service.
- CLCircular — CL Circular: Transforming Global Logistics with Circular Technology. Our mission is to make real-time visibility technology accessible
- DARWIN Biomed — Biomedical Engineering
Biotech VC funding in Spain at a glance
Stats across 461 deals from 349 investors.
Access all 349 VC funds in Spain Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 349 VC funds investing in Spain Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!